Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1035 Neoplasms 813 Carcinoma, Non-Small-Cell Lung 796 Prostatic Neoplasms 617 Colorectal Neoplasms 533 Lung Neoplasms 478 Neoplasm Metastasis 434 Multiple Myeloma 394 Leukemia, Myeloid, Acute 380 Ovarian Neoplasms 333 Pancreatic Neoplasms 316 Melanoma 293 Squamous Cell Carcinoma of Head and Neck 266 Recurrence 260 Carcinoma, Hepatocellular 248 Glioblastoma 237 Brain Neoplasms 236 Triple Negative Breast Neoplasms 213 Head and Neck Neoplasms 210 Carcinoma, Renal Cell 207 Precursor Cell Lymphoblastic Leukemia-Lymphoma 203 Lymphoma 198 Stomach Neoplasms 197 Endometrial Neoplasms 190 Uterine Cervical Neoplasms 182 Lymphoma, Non-Hodgkin 182 Sarcoma 180 Glioma 179 Lymphoma, Large B-Cell, Diffuse 166 Hematologic Neoplasms 162

Interventions

Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Optic Neuritis × 90 days × Clear all

NCT07100990 2026-05-05

TIMELY-PLEX

Mayo Clinic

Phase 3 Recruiting

Myelitis, Myelitis, Transverse, Optic Neuritis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡